These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28957453)

  • 21. [New vaccines against group B meningococcal diseases].
    Hietalahti J; Meri S
    Duodecim; 2015; 131(6):525-32. PubMed ID: 26237895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucosal immunity and optimizing protection with meningococcal serogroup B vaccines.
    Heyderman RS; Davenport V; Williams NA
    Trends Microbiol; 2006 Mar; 14(3):120-4. PubMed ID: 16469496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uncloaking the meningococcus: dynamics of carriage and disease.
    Stephens DS
    Lancet; 1999 Mar; 353(9157):941-2. PubMed ID: 10459897
    [No Abstract]   [Full Text] [Related]  

  • 24. The 15th International Pathogenic Neisseria Conference.
    Tapsall J
    Future Microbiol; 2006 Dec; 1(4):363-4. PubMed ID: 17661628
    [No Abstract]   [Full Text] [Related]  

  • 25. Emerging resistance in Neisseria meningitidis and Neisseria gonorrhoeae.
    Stefanelli P
    Expert Rev Anti Infect Ther; 2011 Feb; 9(2):237-44. PubMed ID: 21342071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infectious diseases. Bacterial meningitis finds new niche in gay communities.
    Kupferschmidt K
    Science; 2013 Jul; 341(6144):328. PubMed ID: 23888010
    [No Abstract]   [Full Text] [Related]  

  • 27. Authors' response: Meningococcal vaccine antigen diversity in global databases.
    Brehony C; Hill DM; Lucidarme J; Borrow R; Maiden MC
    Euro Surveill; 2016 Apr; 21(15):. PubMed ID: 27104935
    [No Abstract]   [Full Text] [Related]  

  • 28. Genomics of Neisseria meningitidis.
    Nassif X
    Int J Med Microbiol; 2002 Feb; 291(6-7):419-23. PubMed ID: 11890539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of BC meningococcal vaccine in Brazil.
    Nishioka S
    Int J Epidemiol; 1996 Oct; 25(5):1102-3. PubMed ID: 8921501
    [No Abstract]   [Full Text] [Related]  

  • 30. Genome analysis and strain comparison of correia repeats and correia repeat-enclosed elements in pathogenic Neisseria.
    Liu SV; Saunders NJ; Jeffries A; Rest RF
    J Bacteriol; 2002 Nov; 184(22):6163-73. PubMed ID: 12399486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances towards the prevention of meningococcal B disease: a multidimensional story.
    Roderick M; Finn A
    J Infect; 2014 Jan; 68 Suppl 1():S76-82. PubMed ID: 24139188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global transmission of multiple-drug resistant Neisseria gonorrhoeae strains refractive to cephalosporin treatment.
    Li SY
    J Formos Med Assoc; 2012 Sep; 111(9):463-4. PubMed ID: 23021501
    [No Abstract]   [Full Text] [Related]  

  • 33. NadA, a novel vaccine candidate of Neisseria meningitidis.
    Comanducci M; Bambini S; Brunelli B; Adu-Bobie J; Aricò B; Capecchi B; Giuliani MM; Masignani V; Santini L; Savino S; Granoff DM; Caugant DA; Pizza M; Rappuoli R; Mora M
    J Exp Med; 2002 Jun; 195(11):1445-54. PubMed ID: 12045242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defences against meningococcal infections.
    Lancet; 1985 Oct; 2(8461):929-30. PubMed ID: 2865427
    [No Abstract]   [Full Text] [Related]  

  • 35. Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant.
    Bottazzi B; Santini L; Savino S; Giuliani MM; Dueñas Díez AI; Mancuso G; Beninati C; Sironi M; Valentino S; Deban L; Garlanda C; Teti G; Pizza M; Rappuoli R; Mantovani A
    PLoS One; 2015; 10(3):e0120807. PubMed ID: 25786110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative genomics identifies the genetic islands that distinguish Neisseria meningitidis, the agent of cerebrospinal meningitis, from other Neisseria species.
    Perrin A; Bonacorsi S; Carbonnelle E; Talibi D; Dessen P; Nassif X; Tinsley C
    Infect Immun; 2002 Dec; 70(12):7063-72. PubMed ID: 12438387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges for development of meningococcal vaccines in infants and children.
    Deasy A; Read RC
    Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.
    MenAfriCar consortium
    J Infect Dis; 2015 Oct; 212(8):1298-307. PubMed ID: 25858956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meningococcal disease control in countries of the African meningitis belt, 2014.
    Wkly Epidemiol Rec; 2015 Mar; 90(13):123-31. PubMed ID: 25816448
    [No Abstract]   [Full Text] [Related]  

  • 40. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.